These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26766303)

  • 1. Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery.
    Zhang L; Sang Y; Feng J; Li Z; Zhao A
    J Drug Target; 2016 Aug; 24(7):579-89. PubMed ID: 26766303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review.
    Cui M; Zhang M; Liu K
    Carbohydr Polym; 2021 Nov; 272():118530. PubMed ID: 34420762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharides: a targeting strategy for colonic drug delivery.
    Shah N; Shah T; Amin A
    Expert Opin Drug Deliv; 2011 Jun; 8(6):779-96. PubMed ID: 21506904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.
    Yuan H; Guo C; Liu L; Zhao L; Zhang Y; Yin T; He H; Gou J; Pan B; Tang X
    Carbohydr Polym; 2023 Jul; 312():120838. PubMed ID: 37059563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.
    Melero A; Draheim C; Hansen S; Giner E; Carreras JJ; Talens-Visconti R; Garrigues TM; Peris JE; Recio MC; Giner R; Lehr CM
    Eur J Pharm Biopharm; 2017 Oct; 119():361-371. PubMed ID: 28709903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Developments in the Area of Click-Crosslinked Nanocarriers for Drug Delivery.
    Dai Y; Chen X; Zhang X
    Macromol Rapid Commun; 2019 Feb; 40(3):e1800541. PubMed ID: 30417477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel prospective in colon specific drug delivery system.
    Bansal V; Malviya R; Malaviya T; Sharma PK
    Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols.
    Tie S; Tan M
    J Agric Food Chem; 2022 Feb; 70(4):903-915. PubMed ID: 35072455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
    Date AA; Hanes J; Ensign LM
    J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
    Hua S; Marks E; Schneider JJ; Keely S
    Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study.
    Preisig D; Varum F; Bravo R; Hartig C; Spleiss J; Abbes S; Caobelli F; Wild D; Puchkov M; Huwyler J; Haschke M
    Eur J Pharm Biopharm; 2021 Aug; 165():22-30. PubMed ID: 33971274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro and nanoscale technologies in oral drug delivery.
    Ahadian S; Finbloom JA; Mofidfar M; Diltemiz SE; Nasrollahi F; Davoodi E; Hosseini V; Mylonaki I; Sangabathuni S; Montazerian H; Fetah K; Nasiri R; Dokmeci MR; Stevens MM; Desai TA; Khademhosseini A
    Adv Drug Deliv Rev; 2020; 157():37-62. PubMed ID: 32707147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier.
    Dey M; Das M; Chowhan A; Giri TK
    Int J Biol Macromol; 2019 Jun; 130():34-49. PubMed ID: 30779985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.
    Dos Santos AM; Carvalho SG; Meneguin AB; Sábio RM; Gremião MPD; Chorilli M
    J Control Release; 2021 Jun; 334():353-366. PubMed ID: 33901582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic opportunities in colon-specific drug-delivery systems.
    Patel M; Shah T; Amin A
    Crit Rev Ther Drug Carrier Syst; 2007; 24(2):147-202. PubMed ID: 17725524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.